Physician profile
William E Bruner
NPI 1639123367
$2,699.63
in general payments reported to CMS, 2019-2025
25 companies · $564 in 2025
The $564 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $97.07 · 2021: $311 · 2022: $562 · 2023: $414 · 2024: $500 · 2025: $564.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,477.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $413.33 | 2022-2025 | Durysta, Ubrelvy |
| Oyster Point Pharma, INC. | $324.40 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Novartis Pharmaceuticals Corporation | $223.73 | 2019-2023 | |
| Mallinckrodt Hospital Products INC. | $216.08 | 2020-2023 | Acthar |
| Bausch & Lomb Americas INC. | $176.93 | 2023-2025 | Xiidra, Vyzulta, Lotemax Sm |
| Sun Pharmaceutical Industries INC. | $175.38 | 2019-2025 | Cequa |
| Allergan, INC. | $166.25 | 2019-2022 | |
| Dompe US, INC. | $165.79 | 2019-2024 | Oxervate |
| Hologic Sales and Service, LLC | $143.65 | 2022-2025 | Aptima, Fluent Fluid Management System, Myosure Tissue Removal Device |
| Alcon Vision LLC | $117.47 | 2024-2025 | Clareon, Lensx, Tryptyr |
| Johnson & Johnson Surgical Vision, INC. | $103.37 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $76.79 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $66.38 | 2024-2025 | Vevye, Iheezo, Triesence |
| Amgen INC. | $61.92 | 2024-2025 | Tepezza |
| Thea Pharma INC. | $45.46 | 2025 | Iyuzeh |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $45.32 | 2019-2021 | |
| Optumhealth Care Solutions, LLC | $30.46 | 2024-2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Organogenesis INC. | $27.55 | 2025 | Puraply Wound Matrix |
| Glaukos Corporation | $25.43 | 2025 | Istent Infinite, Idosetr |
| Axonics, INC. | $19.91 | 2024 | Axonics |
| New World Medical,INC. | $16.96 | 2023 | |
| Spark Therapeutics, INC. | $16.20 | 2022 | |
| Apellis Pharmaceuticals, INC. | $14.30 | 2025 | Syfovre |
| Shire North American Group INC | $13.68 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $12.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Bruner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.